Challenges in treating Staphylococcus epidermidis ventriculitis:The role of biofilm formation and antimicrobial resistance

  • Esteban Perez University of Incarnate Word, UT Health San Antonio (Translational Sciences Program) https://orcid.org/0000-0003-1024-3260
  • Amritpal Dhot University of Incarnate Word
  • Anish Saikumar University of Incarnate Word
  • Francisco Flores Guardado University of Incarnate Word

Abstract

Ventriculitis caused by Staphylococcus epidermidis presents significant management challenges due to biofilm formation and antimicrobial resistance, particularly in patients with external ventricular drains (EVDs). This case report highlights the complexities of treating S. epidermidis-associated ventriculitis and the role of combination antibiotic therapy in overcoming persistent infection.

A 54-year-old male with diabetes mellitus and hypertension presented with altered mental status and was diagnosed with a spontaneous hemorrhage in the left basal ganglia. An EVD was placed for intracranial pressure management, but the patient subsequently developed ventriculitis, confirmed by cerebrospinal fluid (CSF) cultures positive for S. epidermidis. Initial treatment with IV Vancomycin failed to eradicate the infection, prompting the addition of Rifampin, a strategy supported by literature on biofilm-associated infections. The patient’s clinical course was further complicated by a non-occlusive pulmonary embolism.

This case underscores the limitations of vancomycin monotherapy against biofilm-associated S. epidermidis infections and highlights the efficacy of Rifampin in achieving bacterial clearance. Notably, CSF cultures remained persistently positive until rifampin was introduced, leading to the first negative culture and eventual placement of a ventriculoperitoneal shunt. Coagulase-negative staphylococci, including S. epidermidis, account for 50-75% of central nervous system (CNS) shunt infections and typically elicit a less robust inflammatory response, complicating early diagnosis. Our findings emphasize the need for early recognition of biofilm formation and prompt initiation of targeted antimicrobial therapy to improve outcomes in CNS device-related infections. This case supports the use of combination antibiotic therapy and device management as critical components in treating biofilm-associated ventriculitis.

Keywords: Staphylococcus epidermidis, ventriculitis, biofilm, rifampin, antimicrobial resistance

Downloads

Download data is not yet available.

Author Biography

Esteban Perez, University of Incarnate Word, UT Health San Antonio (Translational Sciences Program)

Esteban is an Internal medicine resident and a graduate student in the translational science PHD program studying host pathogen interactions under the mentorship of Larry Schlesinger, MD.  Esteban joined the Schlesinger lab in the fall of 2019 during his 3rd year of medical school. Esteban’s current research project is focused on characterizing the role of AIM2 in human macrophages during early tuberculosis infection. Esteban is considering specializing in Infectious disease or pulmonology for his clinical training.

Research Topic

Infectious disease, Host-pathogen interactions, Tuberculosis

Education

DO, University of Incarnate Word School of Osteopathic Medicine 2021

B.S., Biology, University of Florida, 2015

Publications

Simper JD, Perez E, Schlesinger LS, Azad AK. Resistance and Susceptibility Immune Factors at Play during Mycobacterium tuberculosis Infection of Macrophages. Pathogens. 2022 Oct 6;11(10):1153. doi: 10.3390/pathogens11101153. PMID: 36297211; PMCID: PMC9611686

Perez, E. and Choe, K. (2014), Urea protects Caenorhabditis elegans against hypertonic stress: a genetic model for cellular responses to urea? (1099.7). The FASEB Journal, 28: 1099.7. https://doi.org/10.1096/fasebj.28.1_supplement.1099.7

References

References are within the text file attached.
Published
2026-07-07